Mercury Laboratories share news, announcements and annual reports
BSE: 538964Pharmaceuticals & BiotechnologySmall Cap
Mercury Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2015
Last close ₹790.00up ₹56.00 (7.63%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹734.00.
30 Oct: open ₹790.00, high ₹790.00, low ₹790.00
52-week range of traded prices to 30 Oct 2026
₹620.55Low, 24 Apr 2026₹928.50High, 26 May 2026
- Next results date: the board meets on 5 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹95 Cr2,954th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 22.77
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.63
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.44%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.13
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1
Mercury Laboratories board meetings
109 filed, newest first. Page 2 of 3.
May 2022
18 May · Board meeting
Meeting on 26 May 2022: audited results, final dividend and annual general meeting
Jan 2022
21 Jan · Board meeting
Meeting on 31 Jan 2022: quarterly results
Oct 2021
12 Oct · Board meeting
Meeting on 21 Oct 2021: quarterly results
Aug 2021
2 Aug · Board meeting
Meeting on 10 Aug 2021: quarterly results
May 2021
19 May · Board meeting
Meeting on 27 May 2021: quarterly results, audited results, annual general meeting and final dividend
Feb 2021
2 Feb · Board meeting
Meeting on 11 Feb 2021: interim dividend and quarterly results
Nov 2020
Oct 2020
26 Oct · Board meeting
Meeting on 6 Nov 2020: quarterly results
Aug 2020
Jul 2020
30 Jul · Board meeting
Meeting on 7 Aug 2020: quarterly results1 Jul · Board meeting
Meeting on 4 Jul 2020
May 2020
20 May · Board meeting
Meeting on 30 May 2020: final dividend, audited results, annual general meeting and quarterly results
Jan 2020
28 Jan · Board meeting
Meeting on 5 Feb 2020: quarterly results
Nov 2019
5 Nov · Board meeting
Meeting on 13 Nov 2019: quarterly results
Jul 2019
22 Jul · Board meeting
Meeting on 29 Jul 2019: quarterly results
May 2019
21 May · Board meeting
Meeting on 29 May 2019: audited results, annual general meeting and final dividend
Jan 2019
22 Jan · Board meeting
Meeting on 30 Jan 2019: quarterly results
Nov 2018
1 Nov · Board meeting
Oct 2018
Aug 2018
May 2018
Jan 2018
27 Jan · Board meeting
Nov 2017
25 Nov · Board meeting
Aug 2017
18 Aug · Board meeting